Cells of the immune system

This chapter has zero relevance to any specific element of Section S  from the 2023 CICM Primary Syllabus.  It is not clear whether trainees are expected to know any of this material, nor is it clear that grown-ass intensivists would find any value in it. Second part exam questions about leukocyte abnormalities and neutropenia can be interpreted as vague movements in this direction, but no question has historically asked about these cells or their functions directly. And rightly so, as critical care staff are not histologists who would ever be relied upon to identify them under the microscope, nor haematologists who would be called upon to interpret their abnormalities, nor immunologists who would be asked to manage their function, nor oncologists who would be expected to control their overpopulation. Intensive care specialists can be, at most, expected to look upon the abnormal number in the blood results, and benumb themselves about the depressing prospects of speaking to the family. Still, from some internal place of professional scientific curiosity there must come some questions, such as "what are these cells, and what do they do, and what happens when they do too much or not enough, and how to stop them, or to make them go harder". 

In summary:

Cell type Structure Distribution Function Causes of a high count Causes of a low count Suppressing agents Activity enhancers
Neutrophils
  • 12–15 μm
  • Multilobed nucleus
  • Neutrophilic granules peroxidase negative
  • Azurophilic granules peroxidase positive
  • Lysozyme in both granule types
  • Most numerous leukocyte
  • Mostly bone marrow reservoir
  • Short lived 8–20 h
  • Constant production
  • Rapid migration
  • Phagocytosis
  • Degranulation
  • Respiratory burst
  • Chemotaxis via IL-8
  • Increased production leukaemia CSFs ATRA
  • Increased release stress sepsis corticosteroids
  • Decreased sequestration glucocorticoids
  • Decreased clearance chronic inflammation splenectomy
  • Spurious analyser artefacts
  • Decreased production:  marrow failure, chemo toxins, congenital deficiency
  • Increased destruction: plasmapheresis, haemodialysis
  • Sequestration: hypersplenism
  • Cytotoxic chemotherapy
  • Corticosteroids, NSAIDs, methotrexate, colchicine
  • Anti-IL-17A monoclonal antibodies
  • G-CSF
  • All-trans retinoic acid
  • Azithromycin
  • Vitamin C
Macrophages
  • 20–40 μm
  • Single nucleus
  • No granules
  • Vacuoles and lysosomes
  • Largest immune mass long lived
  • Tissue residents Kupffer alveolar Langerhans microglia
  • Monocytes minor replenishment
  • Phagocytosis via PRRs
  • Antigen presentation MHC II
  • Cytokines IL-1β TNFα IL-6 IL-12
  • Tissue repair M2
  • Debris scavenging
  • Inflammation, stress, exercise, tissue injury
  • TB, malaria, syphilis, listeria
  • Myeloproliferative disorders
  • Decreased clearance, eg. splenectomy
  • Acute recruitment into tissues
  • Reduced production: chemotherapy, leukaemia, aplasia, corticosteroids
  • Viral illness
  • Corticosteroids
  • Proliferation inhibitors
  • Effector blockers: infliximab, etanercept
  • G-CSF
  • All-trans retinoic acid
  • Azithromycin
  • Vitamin C
Eosinophils
  • About 15 μm
  • Bilobed nucleus
  • Granules major basic protein cationic protein peroxidase
  • About 80 percent bone marrow
  • GI tract residents
  • Programmed apoptosis about 5 days
  • Blood half life 8–18 h
  • Antihelminthic and antifungal cytotoxicity
  • Some antibacterial activity
  • Limited phagocytosis
  • Primary myeloproliferative disease, idiopathic hypereosinophilia
  • GM-CSF signals
  • Parasites, protozoa, fungi
  • Hypersensitivity, atopy, SJS, DRESS, eosinophilic oesophagitis
  • Connective tissue disease, EGPA, eosinophilic myalgia
  • Bone marrow suppression
  • Increased margination sepsis corticosteroids
  • Depleting drugs anti-IL-5 monoclonals
  • Corticosteroids
  • Interferon
  • Leukotriene receptor antagonists
  • Cromolyn nedocromil
  • Theophylline
  • Anti-IL-5 monoclonals
  • Beta-2 agonists
Basophils
  • 10–15 μm
  • S shaped or bilobed nucleus
  • Granules heparin sulfates PAF histamine
  • Bone marrow and spleen
  • Blood lifespan about 60 h
  • Reload granules after degranulation
  • Rare in tissues except pathology
  • RES clearance
  • Antiparasitic ticks helminths
  • Weep and sweep via histamine IL-4
  • Th2 skew and antigen presentation
  • B cell activation via IgD
  • Ectoparasites
  • IgE mediated hypersensitivity
  • Autoimmune UC, juvenile arthritis
  • Myeloproliferative disorders, CML, basophilic leukaemia
  • Leukocytosis
  • Haemorrhage
  • Reduced production corticosteroids malignancy congenital
  • Post degranulation urticaria anaphylaxis
  • Thyroid states ovulation
  • Corticosteroids
  • Antihistamines
  • Dupilumab
  • NSAIDs such as indomethacin
Mast cells
  • Solitary round nucleus
  • About 1000 granules about half cell volume
  • Heparin binding histamine serotonin chymase tryptase
  • Granules stain with cationic dyes
  • Released immature from marrow
  • Mature in tissues about 17 days
  • Long lived
  • Connective tissues skin omentum GIT tongue glans posterior pituitary
  • Replicate extra marrow until mature
  • Antiparasitic weep and sweep
  • Chymase degrade neurotensin activate angiotensin II attract fibroblasts
  • Tryptase activate contact system cleave matrix
  • Mastocytosis cutaneous and systemic
  • Mastocytoma, urticaria pigmentosa, mast cell leukaemia
  • Not really expected to be present in accountable numbers
  • Cladribine
  • Midostaurin, masitinib, avapritinib
  • Dupilumab
  • Adrenaline, antihistamines
  • Montelukast, zileuton
  • Disodium cromoglycate
  • Vitamin C
  • Omalizumab
  • We don't usually want to do this
Natural killer cells
  • 7–9 μm
  • Round nucleus
  • Small azurophilic granules perforin granzyme
  • T cell like without TCR
  • Brief circulation
  • Thymus spleen liver
  • Half life about 10 days
  • Replicate outside marrow
  • Tumour and virus surveillance missing self
  • Cytolysis via immune synapse
  • IFN-γ secretion
  • NK lymphoma
  • Not really expected to be present in accountable numbers
  • Corticosteroids
  • Mycophenolate
  • Sirolimus, everolimus
  • Imatinib, dasatinib, nilotinib
  • Sodium valproate
  • Bortezomib
  • Thalidomide, lenalidomide, pomalidomide
  • Azacytidine, decitabine
  • Interferon
Lymphocytes
  • 10–15 μm
  • Round nucleus
  • No granules scant cytoplasm
  • B cells mature marrow then spleen then lymphoid tissues
  • B cell half life about 3 days peripheral about 8 weeks in tissue
  • Memory B long lived
  • T cells mature thymus
  • Memory T 30–160 days
  • Naive CD4 about 6 years CD8 about 9 years
  • B cells antibodies plasma cells antigen presentation
  • CD4 Th1 IFN-γ activate macrophages
  • CD4 Th2 IL-4 drives IgE eosinophils
  • CD8 cytotoxic granzyme B IFN-γ
  • Leukaemias, lymphomas
  • Infections:
    EBV, CMV, VZV, HIV, HSV, HHV6, basically all viruses; also pertussis, brucellosis, tuberculosis, syphilis, malaria, leprosy, Bartonella henselae (cat scratch fever), as well as Toxoplasma gondii, Trypanosoma cruzi,  Strongyloides, babesiosis, leishmaniasis
  • DRESS, GVHD, HLH, congenital lymphopcytosis
  • "stress" in general
  • Aplastic anaemia, leukaemia, chemotherapy
  • glucocorticoids, antilymphocyte globulin, alemtuzumab, rituximab
  • Alcoholism
  • Zinc deficiency
  • Malnutrition, protein-losing eneteropathy
  • Thoracic duct leak
  • ECMO, extracorporeal circuits
  • All lymphocytes: corticosteroids, baricitinib, mycophenolate, thalidomide, azathioprine, methotrexate, cyclophosphamide
  • B cells: belimumab, atacicept, hydroxychloroquine,  rituximab, obinutuzumab, ofatumumab
  • T cells: dasatinib, cyclosporin, tacrolimus, abatacept basiliximab
  • T cell number anti-thymocyte globulin
  • Plerixafor
  • Levamisole
  • Isoprinosine
  • Imiquimod and resiquimod

 (scroll sideways for more table →)

The reader is invited to suggest any alternative peer-reviewed resources that might be listed here as a "one-stop shop" for immune cell information, as presently none compile all of the necessary work into one small digestable bolus. 

Morphology of leukocytes

Leukocytes, "white" cells of the blood which are in actual fact transparent "colourless globules in the buffy coat of the blood", became so-called seemingly to discriminate them from the red corpuscles, but it is not clear who specifically decided to call them white. It is something probably lost in the 194 pages of Essai d'hématologie pathologique by Gabriel Andral (1843), or a reference to the passing turn of phrase "globules blancs du pus" by de Senac in 1749. It is probably entirely by chance that we do not refer to these cells as achromocytes or diaphanocytes. Lost in the dust of library shelves, in the ancient bound copies of the Journal of the Royal Society of Medicine, a conversation between Sir Humphry Rolleston (1934) and the bacteriologist William Bulloch recalls that:

"the word " leucocyte" made its appearance first in 1855 in M. P. Littre and C. Robin's Dictionnaire de medecine (Nysten); it was probably suggested by, and derived from, the word leucocythemie employed in 1851 by Hughes Bennett (1812-75) in a paper read before the Societe de biologie in Paris, to describe "white-cell blood."

Stain-related names like "neutrophil" and "eosinophil" are usually attributed to Max Schulze, but in fact Schulze never actually used those words and was mostly looking at live unstained specimens, and for him the exploration of a heated leukocyte culture was a tedious detour on his way to the study of nerve endings. These cells need to be killed and stained with hematoxylin and eosin to give them the characteristic appearance that was ultimately described and canonised by Paul Ehrlich around 1878.  We are all indebted to the excellent work by Bodzas et al (2023), who took their old Olympus BX51 (a solid workhorse of the cell scientist) and created a high-resolution dataset containing a total of 16027 annotated image of leukocytes, and then shared them on Figshare.  As the result, the reader is again subjected to the author's inexplicable relentless need to put calipers on everything, which has culminated in a diagram that probably adds nothing to the page, except an extra 770kb of loading time:

It is unlikely that the size and structure of leukocytes will ever form the topic of a question, because whereas in red cells the morphology and volume are suspicious for disease, they are less relevant in white cells. 

Distribution of leukocytes

For the graphics and detail in what follows, we are indebted to the excellent paper by Sender et al (2023), which features amazingly lucid use of graphics to present their scientific content. Their images are borrowed here, shamelessly without permission but with full credit and in homage to the original authors. To summarise their findings for the non-visual learner:

  • The average human contains about 1.2kg of immune cells, which represents about 1.7% of the total population, similar to the standing armies of Kuwait and Austria.  
  • Of these, 
    • About 50% is macrophages, though they are only 10% of the total number (being largest)
    • About 15% is neutrophils, residing mostly in the marrow
    • About 15% is lymphocytes, mostly in the lymph nodes and spleen
    • The rest is mostly mast cells and dendritic cells
  • Of the organs, immune cell distribution is:
    • 40% each in the bone marrow and lymphatic system
    • 10% in the liver (6% of the liver by mass)
    • 3-4% in the lungs
    • 3-4% in the gastrointestinal tract
    • 2% in the blood

References

Sender, Ron, et al. "The total mass, number, and distribution of immune cells in the human body." Proceedings of the National Academy of Sciences 120.44 (2023): e2308511120.

Kovalszki, A., J. Sheikh, and P. F. Weller. "Clinical immunology principles and practice." (2013).

Weaver, Alice D. "The Development of the Knowledge of the Leukocyte." Bulletin of the New York Academy of Medicine 30.12 (1954): 988.

Addison, W. "Colourless globules in the buffy coat of the blood." London Medical Gazette 27.477 (1840): 1841.

Rolleston, Humphry. "The history of haematology." (1934): 1161-1178.

Brewer, Douglas B. "Max Schultze and the living, moving, phagocytosing leucocytes: 1865." Medical history 38.1 (1994): 91-101.

Milroy, T. H. "Histology of the Blood: Normal and Pathological." (1900): 410-411.

Kay, A. Barry. "Paul Ehrlich and the early history of granulocytes." Microbiology spectrum 4.4 (2016): 10-1128.

Ehrlich, Paul. "Beiträge zur Theorie und Praxis der histologischen Färbung." The collected papers of Paul Ehrlich. Pergamon, 2013. 29-64.

Bodzas, Alexandra, Pavel Kodytek, and Jan Zidek. "A high-resolution large-scale dataset of pathological and normal white blood cells." Scientific Data 10.1 (2023): 466.